Covered recipient · General Payments record
ERIC D MORSE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Addiction Psychiatry
General Payments · PY2018–2024
$3,113.99
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $910.36 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $297.78 | 8 |
| Alkermes, Inc. | $152.57 | 4 |
| Axsome Therapeutics, Inc. | $125.00 | 1 |
| Vanda Pharmaceuticals Inc. | $123.20 | 1 |
| Otsuka America Pharmaceutical, Inc. | $121.93 | 1 |
| Braeburn Inc. | $89.88 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $115.42 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069959 | CMS |
| ABBVIE INC. | $17.81 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069961 | CMS |
| ABBVIE INC. | $15.02 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069963 | CMS |
| ABBVIE INC. | $21.26 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069965 | CMS |
| ABBVIE INC. | $5.25 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069967 | CMS |
| ABBVIE INC. | $97.31 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069969 | CMS |
| ABBVIE INC. | $16.47 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069971 | CMS |
| ABBVIE INC. | $9.24 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105069973 | CMS |
| Alkermes, Inc. | $19.43 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120558803 | CMS |
| Alkermes, Inc. | $1.05 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120558805 | CMS |
| Alkermes, Inc. | $10.02 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120558807 | CMS |
| Alkermes, Inc. | $122.07 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120558809 | CMS |
| Axsome Therapeutics, Inc. | $125.00 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148279353 | CMS |
| Braeburn Inc. | $24.61 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601259 | CMS |
| Braeburn Inc. | $21.71 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601265 | CMS |
| Braeburn Inc. | $21.18 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601263 | CMS |
| Braeburn Inc. | $22.38 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601261 | CMS |
| Otsuka America Pharmaceutical, Inc. | $121.93 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118945917 | CMS |
| Vanda Pharmaceuticals Inc. | $123.20 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133913564 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.